Skip to content

Grant Pickering, Chief Executive Officer at Vaxcyte, sold PCVX on Jul 27, 2026

Data as of Oct 16

▼ SELL$654K11,783 shares at $55.52Grant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.
Watch PCVX
Traded
Jul 27, 2026
Disclosed
Jul 28, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Grant Pickering, Chief Executive Officer at Vaxcyte, sold PCVX on Jul 27, 2026TRADEDDISCLOSED
PCVXSimilar stocks (XLV — its sector index fund), rebased to PCVX's price on the disclosure day
PCVX since disclosure
+16.5%
after the sale
Similar stocks (XLV) since disclosure
+5.6%
XLV — its sector index fund

Change in closing price from Jul 28, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLGrant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.$247Kdisclosed Jul 28 · filed 1 day after the trade
  2. ▼ SELLGrant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.$34.5Kdisclosed Jul 28 · filed 1 day after the trade
  3. ▼ SELLGrant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.$21.1Kdisclosed Jul 28 · filed 1 day after the trade
  4. ▼ SELLGrant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.$42Kdisclosed Jul 28 · filed 1 day after the trade
  5. ▼ SELLGrant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.$13.7Kdisclosed Jul 28 · filed 1 day after the trade

See every trade on PCVX →